Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06580912 · ClinicalTrials.gov registry record · Phase 2

Krill Oil for Pain in Elders

A Phase 2 study of Chronic Musculoskeletal Pain, sponsored by University of Florida.

Completed
Registry status
Phase 2
Development phase
40
Enrollment target
1
Study location

NCT06580912 is a Phase 2 study of Chronic Musculoskeletal Pain that has completed, run by University of Florida. The registered enrollment target is 40 participants, below the 432-participant average among 13 other Chronic Musculoskeletal Pain trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06580912, a Phase 2 study of Chronic Musculoskeletal Pain, has completed, sponsored by University of Florida.

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Chronic musculoskeletal pain contributes to mobility disability among older adults. Nutritional interventions, like omega-3 fatty acids, may help manage pain and improve physical function. Supplementation with krill oil may offer advantages to fish oil due to better absorption and additional nutrients. This pilot study aims to assess the feasibility of a clinical trial to determine the impact of krill oil supplementation on pain and function in older adults, informing future research.

Interventions

  • DRUG Krill oil
  • DIETARY_SUPPLEMENT Mixed vegetable oil

Study Locations (1)

Florida

  • UF Claude D. Pepper Older Americans Independence Center - Gainesville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-01-17
Est. Completion 2025-12-17
Phase Phase 2

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT06580912

The ClinicalTrials.gov registry entry for NCT06580912 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 432-participant average among 13 other Chronic Musculoskeletal Pain trials with a reported enrollment target (91% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Musculoskeletal Pain appearing as the primary indexed condition, and to 2 interventions - of which Krill oil is the first listed.

NCT06580912 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06580912 about?

NCT06580912 is a clinical study titled "Krill Oil for Pain in Elders". Chronic musculoskeletal pain contributes to mobility disability among older adults. Nutritional interventions, like omega-3 fatty acids, may help manage pain and improve physical function. Supplementation with krill oil may offer advantages to fish oil due to better absorption and additional nutrien...

What is the current status of trial NCT06580912?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2025-01-17. Estimated completion is 2025-12-17.

What conditions does trial NCT06580912 study?

This clinical trial studies the following conditions: Chronic Musculoskeletal Pain.

What interventions are being tested in trial NCT06580912?

The interventions under investigation include: Krill oil (DRUG), Mixed vegetable oil (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06580912?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06580912 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Musculoskeletal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.